Expansion of Regulatory T cells using Low-dose Interleukin-2 Attenuates Hypertension in an Experimental Model of Autoimmune Disease

被引：0
|
作者：
Taylor, Erin B. [1 ]
Ryan, Michael J. [1 ]
机构：
[1] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA
来源：
FASEB JOURNAL | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1026.9
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Low-Dose Interleukin-2 Therapy Activates Circulating T Follicular Regulatory Cells and Suppresses Circulating T Follicular Helper Cells in Patients with Chronic Gvhd
    Kamihara, Yusuke
    Forcade, Edouard
    Koreth, John
    Liu, Hongye
    Kubo, Tomohiro
    Whangbo, Jennifer
    Hirakawa, Masahiro
    Nikiforow, Sarah
    Ho, Vincent T.
    Armand, Philippe
    Cutler, Corey S.
    Alyea, Edwin, III
    Blazar, Bruce
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    BLOOD, 2017, 130
  • [22] Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
    Matsuoka, Ken-ichi
    Koreth, John
    Kim, Haesook T.
    Bascug, Gregory
    McDonough, Sean
    Kawano, Yutaka
    Murase, Kazuyuki
    Cutler, Corey
    Ho, Vincent T.
    Alyea, Edwin P.
    Armand, Philippe
    Blazar, Bruce R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (179)
  • [23] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon
    Alikhan, M
    Spencer, HJ
    Kohli, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6267 - 6268
  • [24] Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
    Rosenzwajg, Michelle
    Churlaud, Guillaume
    Mallone, Roberto
    Six, Adrien
    Derian, Nicolas
    Chaara, Wahiba
    Lorenzon, Roberta
    Long, S. Alice
    Buckner, Jane H.
    Afonso, Georgia
    Pham, Hang-Phuong
    Hartemann, Agnes
    Yu, Aixin
    Pugliese, Alberto
    Malek, Thomas R.
    Klatzmann, David
    JOURNAL OF AUTOIMMUNITY, 2015, 58 : 48 - 58
  • [25] Low-Dose 5-Aza-2′-deoxycytidine Pretreatment Inhibits Experimental Autoimmune Encephalomyelitis by Induction of Regulatory T Cells
    Chan, Michael W. Y.
    Chang, Chia-Bin
    Tung, Chien-Hsueh
    Sun, Justin
    Suen, Jau-Ling
    Wu, Shu-Fen
    MOLECULAR MEDICINE, 2014, 20 : 248 - 256
  • [26] Low-Dose 5-Aza-2′-deoxycytidine Pretreatment Inhibits Experimental Autoimmune Encephalomyelitis by Induction of Regulatory T Cells
    Michael W. Y. Chan
    Chia-Bin Chang
    Chien-Hsueh Tung
    Justin Sun
    Jau-Ling Suen
    Shu-Fen Wu
    Molecular Medicine, 2014, 20 : 248 - 256
  • [27] Increasing Regulatory T Cells With Interleukin-2 and Interleukin-2 Antibody Complexes Attenuates Lung Inflammation and Heart Failure Progression
    Wang, Huan
    Hou, Lei
    Kwak, Dongmin
    Fassett, John
    Xu, Xin
    Chen, Angela
    Chen, Wei
    Blazar, Bruce R.
    Xu, Yawei
    Hall, Jennifer L.
    Ge, Jun-bo
    Bache, Robert J.
    Chen, Yingjie
    HYPERTENSION, 2016, 68 (01) : 114 - 122
  • [28] Low dose interleukin-2 therapy for ischemic retinopathies: correcting the balance between regulatory T cells and effector T cells
    Deliyanti, Devy
    Yanfaunnas, Faisal Farras
    Joglekar, Amit
    Wilkinson-Berka, Jennifer L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [29] Diabetes mellitus induced by low-dose interleukin-2
    Soni, N
    Meropol, NJ
    Porter, M
    Caligiuri, MA
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 43 (01) : 59 - 62
  • [30] Low-dose interleukin-2 for systemic lupus erythematosus?
    Wallace, Daniel J.
    LANCET RHEUMATOLOGY, 2019, 1 (01): : E7 - E8
12345